The 51 references in paper A. Smirnov V., V. Dobronravov A., I. Kayukov G., А. Смирнов В., В. Добронравов А., И. Каюков Г. (2010) “К ПРОБЛЕМЕ МОДИФИКАЦИИ КЛАССИФИКАЦИИ ХРОНИЧЕСКОЙ БОЛЕЗНИ ПОЧЕК // ABOUT A PROBLEM OF MODIFICATION OF CLASSIFICATION OF CHRONIC KIDNEY DISEASE” / spz:neicon:nefr:y:2010:i:2:p:11-19

1
National Kidney Foundation KD: Clinical practice guidelines for chronic Kidney disease: Evaluation, classification and stratification. Am J Kidney Dis 2002;39 [Suppl 1]: S1-S266
(check this in PDF content)
2
Смирнов АВ, Есаян АМ, Каюков ИГ. Хроническая бо­ лезнь почек: на пути к единству представлений. Нефроло­ гия 2002; 6(4): 11-17
(check this in PDF content)
3
Glassock RJ, Winearls C. The global burden of chronic kidney disease: How valid are the estimates? Nephron Clin Pract 2008;110: 39-47
(check this in PDF content)
4
Glassock RJ, Winearls C. Screening for CKD with eGFR: Doubts and dangers. Clin J Am Soc Nephrol 2008;3: 1563­ 15689
(check this in PDF content)
5
Glassock RJ, Winearls C. An epidemic of chronic kidney disease: Fact or fiction? Nephrol Dial Transplant 2008;23:1117- 1121
(check this in PDF content)
6
Bauer C, Melamed ML, HostetterTH. Staging of chronic kidney disease: Time for a course of correction. J Am Soc Nephrol 2008;19:844-846
(check this in PDF content)
7
LandrayMJ, Haynes RJ. Commentary: Controversies in NICE guidance on chronic kidney disease BMJ 2008;337: a1793
(check this in PDF content)
8
Смирнов АВ, Добронравов ВА, Каюков ИГ, Есаян АМ. Хроническая болезнь почек: дальнейшее развитие концеп­ ции и классификации. Нефрология 2007; 11(4): 7-17
(check this in PDF content)
9
Смирнов АВ, Добронравов ВА, Каюков ИГ. Кардио­ ренальный континуум: патогенетические основы превентив­ ной нефрологии. Нефрология 2005;9(3): 7-15
(check this in PDF content)
10
Majunath G, Tighionart H, Ibrahim H et al. Level of kidney function as a risk factors for atherosclerotic cardiovascular outcomes in the community. J Am Coll Cardiol 2003; 41: 47-55
(check this in PDF content)
11
Henry RM, Kostense PJ, Bos G et al. Mild renal insufficiency is associated with increased cardiovascular mortality: the Hoorn Study. Kidney Int 2002; 62: 1402-1407
(check this in PDF content)
12
Nitsch D, Dietrich DF, von Eckardstein A et al. Prevalence of renal impairment and its association with cardiovascular risk factors in a general population: results of the Swiss SAPALDIA study. Nephrol Dial Transplant 2006; 21(4): 935-944
(check this in PDF content)
13
Segura J, Campo C, Ruilope LM. Effect of proteinuria and glomerular filtration rate on cardiovascular risk in essential hypertension. Kidney Int 2004; [Suppl 92]:S45-9.2004
(check this in PDF content)
14
Mann JFE. Cardiovascular risk in patients with mild renal insufficiency: implication for the use of ACE inhibitors. La Presse Medicale 2005; 34(18): 1303-1308
(check this in PDF content)
15
M y^m ^i J, Sy^nen J, Helin H et al.Vascular diseases and their risk factors in IgA nephropathy. Nephrol Dial Transplant 2006; 21(7):1876-1882
(check this in PDF content)
16
Vanholder R, Massy Z, Argiles A, Spasovski G, Verbeke F, Lameire N; European Uremic Toxin Work Group. Chronic kidney disease as cause of cardiovascular morbidity and mortality. Nephrol Dial Transplant 2005; 20(6):1048-1056
(check this in PDF content)
17
Смирнов АВ, Седов ВМ, Лхаахуу Од-Эрдэнэ, Каю­ ков ИГ и др. Снижение скорости клубочковой фильтрации как независимый фактор риска сердечно-сосудистой бо­ лезни. Нефрология 2006; 10(4): 7-17
(check this in PDF content)
18
Мухин НА, Моисеев ВС, Кобалава ЖД и др. Карди­ оренальные взаимодействия: клиническое значение и роль в патогенезе заболеваний сердечно-сосудистой системы и почек. Тер арх 2004; (6):39-46
(check this in PDF content)
19
Wen CP, Cheng TY Tsai MK et al. All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462 293 adults in Taiwan. Lancet 2008; 371(9631):2173-2182
(check this in PDF content)
20
Couser WG. Chronic kidney disease-The promise and the perils. J Am Soc Nephrol 2007; 18:2803-2805
(check this in PDF content)
21
Bauer C, Melamed ML, Hostetter TH Staging of chronic kidney disease: time for a course correction. J Am Soc Nephrol 2008:19 844-846
(check this in PDF content)
22
Glassock RJ, Winearls C. CKD—fiction not fact. Nephrol Dial Transplant 2008;23:2695-2696
(check this in PDF content)
23
Jong PE, Gansevoort RT. Fact or fiction of the epidemic of chronic kidney disease-let us not squabble about estimated GFR only, but also focus on albuminuria. Nephrol Dial Transplant 2008;23:1092-1095
(check this in PDF content)
24
Poggio ED, Rule AD. Can we do better than single estimated GFR threshold when screening for chronic kidney disease? Kidney Int 2007;72:534-536
(check this in PDF content)
25
Schmieder RE Schrader J, Zidek W et al. Low-grade albuminuria and cardiovascular risk: what is the evidence? Clin Res Cardiol 2007; 96(5):247-257;
(check this in PDF content)
26
Klausen KP Scharling H, Jensen G, Jensen JS. New definition of microalbuminuria in hypertensive subjects: association with incident coronary heart disease and death. Hypertension 2005;46(1):33-37
(check this in PDF content)
27
Glassock RJ, Winearls C. Routine reporting of estimated glomerular filtration rate: Not ready for prime time. Nat Clin Pract Nephrol 2008; (8):422-423
(check this in PDF content)
28
Di Angelantonio E, Danesh J, Eiriksdottir G, Gudnason V. Renal function and risk of coronary heart disease in general populations: New prospective study and systematic review. PLoS Med 2007. doi: 10.1371/journal.pmed.0040270
(check this in PDF content)
29
Shlipak MG, Sarnak MJ, Katz R, Fried LF, Seliger SL et al. Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med 2005; 352: 2049-2060
(check this in PDF content)
30
Wannamethee SG, Shaper AG, Lowe GDO, Lennon L, Rumley A et al. Renal function and cardiovascular mortality in elderly men: the role of inflammatory, procoagulant, and endothelial biomarkers. Eur Heart J 2006;27:2975-2981
(check this in PDF content)
31
Ford I, Bezlyak V, Stott DJ, Sattar N, Packard CJ, Perry I, Buckley BM, Jukema JW, de Craen AJ, Westendorp RG, Shepherd J.Reduced glomerular filtration rate and its association with clinical outcome in older patients at risk of vascular events: secondary analysis. PLoS Med 2009;6(1): e16
(check this in PDF content)
32
Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004;351(13):1296- 305
(check this in PDF content)
33
Brantsma AH, Bakker SJ, Hillege HL, de Zeeuw D, de Jong PE, Gansevoort RT; PREVEND Study Group.Cardiovascular and renal outcome in subjects with K/DOQI stage 1-3 chronic kidney disease: the importance of urinary albumin excretion. Nephrol Dial Transplant 2008; 23(12):3851-3858
(check this in PDF content)
34
Jong PE, van der Velde M, Gansevoort RT, Zoccali C. Screening for chronic kidney disease: where does Europe go? Clin J Am Soc Nephrol 2008;3(2):616-623
(check this in PDF content)
35
Hallan SI, Ritz E, Lydersen S, Romundstad S, Kvenild K, Orth SR. Combining GFR and albuminuria to classify CKD improves prediction of ESRD. J Am Soc Nephrol 2009 20(5):1069-1077
(check this in PDF content)
36
Rutkowski M, Mann W, Derose S, Selevan D, Pascual N, Diesto J, Crooks P. Implementing KDOQI CKD definition and staging guidelines in Southern California Kaiser Permanente. Am J Kidney Dis 2009;53 (3) [Suppl 3]:S86-99
(check this in PDF content)
37
Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS. Prevalence of chronic kidney disease in the United States. JAMA 2007; 298(17):2038-2047
(check this in PDF content)
38
Levey AS, Eckardt KU, TsukamotoY etal. Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2005;67:2089-2100
(check this in PDF content)
39
Смирнов АВ, Добронравов ВА, Каюков ИГ и др. Ре­ комендации Научно-исследовательского института нефро­ логии Санкт-Петербургского государственного медицинского университета им. акад. И.П. Павлова: опре­ деление, классификация, диагностика и основные направ­ ления профилактики хронической болезни почек у взрослых. 2008, Левша, СПб
(check this in PDF content)
40
Froissart M, Rossert J, Jacquot C, Paillard M, Houillier P Predictive performance of the modification of diet in renal disease and Cockcroft-Gault equations for estimating renal function. J Am Soc Nephrol 2005;16(3):763-773
(check this in PDF content)
41
Foley RN, Wang C, Snyder JJ, Collins AJ. Cystatin C levels in U.S. adults, 1988-1994 versus 1999-2002: NHANES. Clin J Am Soc Nephrol 2009; 4(5):965-972
(check this in PDF content)
42
Botev R, Mallie JP, Couchoud C, Schuck O, Fauvel JP, Wetzels JF, Lee N, De Santo NG, Cirillo M. Estimating glomerular filtration rate: Cockcroft-Gault and Modification of Diet in Renal Disease formulas compared to renal inulin clearance. Clin J Am Soc Nephrol 2009 4(5):899-906
(check this in PDF content)
43
Levey AS, Bosch JP, Lewis JB. A more accurate method to estimate glomerular filtration rate from serum creatinine; a new prediction equation. Ann Intern Med 1999;130(8): 461-470
(check this in PDF content)
44
Ma YC, Zuo L, Chen JH, Luo Q, Yu XQ, Li Y Xu JS, Huang SM, Wang LN, Huang W, Wang M, Xu GB, Wang HY Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol 2006;17(10):2937-2944
(check this in PDF content)
45
Rule AD, Larson TS, Bergstralh EJ, Slezak JM, Jacobsen SJ, Cosio FG. Using serum creatinine to estimate glomerular filtration rate: accuracy in good health and in chronic kidney disease. Ann Intern Med 2004;141(12):929-937
(check this in PDF content)
46
Horio M, Imai E, Yasuda Y, Watanabe T, Matsuo S. Modification of the CKD Epidemiology Collaboration (CKD- EPI) Equation for Japanese: Accuracy and Use for Population Estimates. Am J Kidney Dis 2010 (in press)
(check this in PDF content)
47
Glassock RJ, Winearls C. CKD in the elderly. Am J Kidney Dis 2008; 52:803
(check this in PDF content)
48
knoyan G. Kidney disease: Wherefore, whence and whereto? Kidney Int 2007; 71: 473-475
(check this in PDF content)
49
Levey AS, Eckardt KU, Tsukamoto Y et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2005; 67(6): 2089-20100
(check this in PDF content)
50
Волков ММ, Смирнов АВ, Дегтерева ОА, Шевякова ЕВ, Трофименко ИИ, Панина ИЮ. Кальциноз клапанного ап­ парата сердца и состояние миокарда у пациентов в додиа­ лизном периоде хронической болезни почек. Нефрология 2008;12(1): 46-52
(check this in PDF content)
51
Волков ММ, Смирнов АВ, Дегтерева ОА, Шевякова ЕВ. Дисфункции миокарда, оцениваемые методом ткане­ вой допплерографии и фосфорно-кальциевый баланс у пациентов на хроническом гемодиализе. Нефрология 2008;12(3):18-23
(check this in PDF content)